14 April 2023 - Overpaying for medicines diverts funds away from other treatments and services. ...
4 February 2023 - The mission of NICE is to get the best care to patients fast, while ensuring value for ...
2 November 2022 - Advances in the digitisation of health systems and expedited regulatory approvals of innovative treatments have led to ...
8 September 2022 - The decision by the UK National Institute for Health and Care Excellence not to recommend esketamine ...
6 September 2022 - The Institute of Cancer Research, London, has expressed disappointment that NICE has confirmed its decision not ...
15 August 2022 - The UK Government has said that it will not procure the COVID-19 drug Evusheld—a combination of ...
8 July 2022 - We read with great interest the recently published article by Patel et al. and commend the authors ...
25 May 2022 - Evidence about the relative effects of new treatments is typically collected in randomised controlled trials. ...
5 May 2022 - NICE's expert group RAPID C-19, set up to ‘to ensure safe and timely patient access to treatments ...
31 January 2022 - This study outlines the ways in which different health technology assessment organizations deal with uncertainty in relative ...
31 January 2022 - Adequate methods are urgently needed to guarantee the good practice of health technology assessment for technologies with ...
19 January 2022 - The health technology assessment body has been under pressure from drugmakers and patient groups for years to ...
19 November 2021 - Godlee’s call for the National Institute for Health and Care Excellence to keep close to its radical ...
6 October 2021 - Collaboration will leverage the Aetion Evidence Platform to study when and how real world evidence can support ...
15 July 2021 - As health technology assessment seeks to combine complex sets of evidence, values, and perspectives to support open, ...